Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on January 22, 2004

Arteriosclerosis, Thrombosis, and Vascular Biology. 2004
Published online before print January 22, 2004, doi: 10.1161/01.ATV.0000118279.74056.8a
A more recent version of this article appeared on March 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/3/601    most recent
01.ATV.0000118279.74056.8av1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindenblatt, N.
Right arrow Articles by Vollmar, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindenblatt, N.
Right arrow Articles by Vollmar, B.
Related Collections
Right arrow Animal models of human disease
Right arrow Aggregation
Right arrow Platelets
Right arrow Endothelium/vascular type/nitric oxide

Submitted on November 14, 2003
Accepted on December 9, 2003

Vascular Heme Oxygenase-1 Induction Suppresses Microvascular Thrombus Formation In Vivo

N. Lindenblatt ; R. Bordel ; W. Schareck ; M. D. Menger ; and B. Vollmar *

From the Department of Experimental Surgery (N.L., R.B., B.V.) and the Department of General Surgery (N.L., W.S.), University of Rostock, Rostock, Germany; and the Department of Clinical-Experimental Surgery (M.D.M.), University of Saarland, Homburg/Saar, Germany.

* To whom correspondence should be addressed. E-mail: brigitte.vollmar{at}med.uni-rostock.de.

Objective--By heme degradation, heme oxygenase-1 (HO-1) provides endogenous carbon monoxide and bilirubin, both of which play major roles in vascular biology. The current study aimed to examine whether induction of HO-1 and its byproducts modulate the process of microvascular thrombus formation in vivo.

Methods and Results--In individual microvessels of mouse cremaster muscle preparations, ferric chloride-induced thrombus formation was analyzed using intravital fluorescence microscopy. When mice were pretreated with an intraperitoneal injection of hemin, a HO-1 inducer, immunohistochemistry and Western blot protein analysis of cremaster muscle tissue displayed a marked induction of HO-1. In these animals, superfusion with ferric chloride solution induced arteriolar and venular thrombus formation, which, however, was significantly delayed when compared with thrombus formation in animals without HO-1 induction. The delay in thrombus formation in hemin-treated mice was completely blunted by tin protoporphyrin-IX, a HO-1 inhibitor, but not by copper protoporphyrin-IX, which does not inhibit the enzyme. Coadministration of the vitamin E analogue Trolox in HO-1-blocked animals almost completely restored the delay in thrombus formation, implying that, besides CO, the antioxidant HO pathway metabolite bilirubin mainly contributes to the antithrombotic property of HO-1. This was further supported by the fact that bilirubin was found as effective as hemin in delay of ferric chloride-induced thrombus formation. Animals with HO-1 induction revealed reduced P-selectin protein expression in cremaster muscle tissue, which most probably presented the molecular basis for delayed thrombus growth.

Conclusion--Local induction of HO-1 activity may be of preventive and therapeutic value for clinical disorders with increased risk of thrombotic events.


Key words: thrombosis • platelet • leukocyte • fluorescence microscopy • heme oxygenase • carbon monoxide • bilirubin • P-selectin




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
B. Chen, L. Guo, C. Fan, S. Bolisetty, R. Joseph, M. M. Wright, A. Agarwal, and J. F. George
Carbon Monoxide Rescues Heme Oxygenase-1-Deficient Mice from Arterial Thrombosis in Allogeneic Aortic Transplantation
Am. J. Pathol., July 1, 2009; 175(1): 422 - 429.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. Rantner, B. Kollerits, M. Anderwald-Stadler, P. Klein-Weigel, I. Gruber, A. Gehringer, M. Haak, M. Schnapka-Kopf, G. Fraedrich, and F. Kronenberg
Association between the UGT1A1 TA-Repeat Polymorphism and Bilirubin Concentration in Patients with Intermittent Claudication: Results from the CAVASIC Study
Clin. Chem., May 1, 2008; 54(5): 851 - 857.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. S. Perlstein, R. L. Pande, J. A. Beckman, and M. A. Creager
Serum Total Bilirubin Level and Prevalent Lower-Extremity Peripheral Arterial Disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004
Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 166 - 172.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Lindenblatt, M. D. Menger, E. Klar, and B. Vollmar
Darbepoetin-Alpha Does Not Promote Microvascular Thrombus Formation in Mice: Role of eNOS-Dependent Protection Through Platelet and Endothelial Cell Deactivation
Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1191 - 1198.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. P. Juncos, J. P. Grande, N. Murali, A. J. Croatt, L. A. Juncos, R. P. Hebbel, Z. S. Katusic, and K. A. Nath
Anomalous Renal Effects of Tin Protoporphyrin in a Murine Model of Sickle Cell Disease
Am. J. Pathol., July 1, 2006; 169(1): 21 - 31.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Lindenblatt, M. D. Menger, E. Klar, and B. Vollmar
Sustained hypothermia accelerates microvascular thrombus formation in mice
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2680 - H2687.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Kapitulnik
Bilirubin: An Endogenous Product of Heme Degradation with Both Cytotoxic and Cytoprotective Properties
Mol. Pharmacol., October 1, 2004; 66(4): 773 - 779.
[Full Text] [PDF]